DNA binding, cytotoxicity, and apoptotic-inducing activity of ruthenium(II) polypyridyl complex

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 7, 2010, Pages 440-449

  Zhang, Peng ^a   Chen, Jie ^a   Liang, Yi ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

apoptosis; binding affinity; cytotoxicity; isothermal titration calorimetry; molecular recognition

Indexed keywords

2,2' BIPYRIDINE; CALF THYMUS DNA; DNA; INTERCALATING AGENT; ORGANOMETALLIC COMPOUND; RUTHENIUM;

ANIMAL; APOPTOSIS; ARTICLE; BINDING COMPETITION; CALORIMETRY; CATTLE; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; CONFORMATION; DOSE RESPONSE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; METABOLISM; THERMODYNAMICS; TUMOR CELL LINE;

2,2'-DIPYRIDYL; ANIMALS; APOPTOSIS; BINDING, COMPETITIVE; CALORIMETRY; CATTLE; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CIRCULAR DICHROISM; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; INTERCALATING AGENTS; MOLECULAR STRUCTURE; NUCLEIC ACID CONFORMATION; ORGANOMETALLIC COMPOUNDS; RUTHENIUM; THERMODYNAMICS;

EID: 77954406250     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq040     Document Type: Article

References (42)

1. Greguric I, Aldrich-Wright JR and Collins JG. A 1H NMR study of the binding of D-[Ru(phen)2DPQ]2+ to the hexanucleotide d(GTCGAC)2: evidence for intercalation from the minor groove. J Am Chem Soc 1997, 119: 3621-3622.
2. Nair RB, Teng ES, Kirkland SL and Murphy CJ. Synthesis and DNA-binding properties of [Ru(NH3)4dppz]2+. Inorg Chem 1998, 37: 139-141.
3. Tan CP, Liu J, Chen LM, Shi S and Ji LN. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. J Inorg Biochem 2008, 102: 1644-1653.
4. Zhang CX and Lippard SJ. New metal complexes as potential therapeutics. Curr Opin Chem Biol 2003, 7: 481-489.
5. Kostova I. Ruthenium complexes as anticancer agents. Curr Med Chem 2006, 13: 1085-1107.
6. Xu H, Deng H, Zhang QL, Huang Y, Liu JZ and Ji LN. Synthesis and spectroscopic RNA binding studies of [Ru(phen)2MHPIP]2+. Inorg Chem Commun 2003, 6: 766-768.
7. Xu H, Liang Y, Zhang P, Du F, Zhou BR, Wu J and Liu JH, et al. Biophysical studies of a ruthenium(II) polypyridyl complex binding to DNA and RNA prove that nucleic acid structure has significant effects on binding behaviors. J Biol Inorg Chem 2005, 10: 529-538.
8. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007, 7: 573-584.
9. Brabec V. DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair. Prog Nucleic Acid Res Mol Biol 2002, 71: 1-68.
10. Nováková O, Kaspárková J, Vrána O, Van Vliet PM, Reedijk J and Brabec V. Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes. Biochemistry 1995, 34: 12369-12378.
11. Alessio E, Mestroni G, Bergamo A and Sava G. Ruthenium antimetastatic agents. Curr Top Med Chem 2004, 4: 1525-1535.
12. Hartinger CG, Zorbas-Selfried S, Jakupee MA, Kynast B, Zorbas H and Keppler BK. From bench to bedside-preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III) ] (KP1019 or FFC14A). J Inorg Biochem 2006, 100: 891-904.
13. Brabec V and Novákoá O. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Drug Resist Update 2006, 9: 111-122.
14. Chaires JB. Energetics of drug-DNA interactions. Biopolymers 1998, 44: 201-215.
15. Haq I. Thermodynamics of drug-DNA interactions. Arch Biochem Biophys 2002, 403: 1-15.
16. Buurma NJ and Haq I. Advances in the analysis of isothermal titration calorimetry data for ligand-DNA interactions. Methods 2007, 42: 162-172.
17. Wu J, Du F, Zhang P, Khan IA, Chen J and Liang Y. Thermodynamics of the interaction of aluminum ions with DNA: implications for the biological function of aluminum. J Inorg Biochem 2005, 99: 1145-1154.
18. Liang Y. Applications of isothermal titration calorimetry in protein science. Acta Biochim Biophys Sin 2008, 40: 565-576.
19. Reichmann ME, Rice SA, Thomas CA and Doty P. A further examination of the molecular weight and size of desoxypentose nucleic acid. J Am Chem Soc 1954, 76: 3047-3053.
20. Amouyal E, Homsi A, Chambron JC and Sauvage JP. Synthesis and study of a mixed-ligand ruthenium(II) complex in its ground and excited states: bis(2,2-bipyridine)(dipyrido[3,2-a:2,3-c]phenazine-N4N5)ruthenium(II). Dalton Trans 1990, 6: 1841-1845.
21. Xiong Y, Zhou XH, Wu JH, Ji LN, Li RH, Zhou JY and Yu KB. Synthesis, structure and DNA-binding studies on the 2-(3-chlorophenyl) imidazo[4,5-f]1,10- phenanthroline-bis(2,20-bipyridine)-ruthenium(II) complex. Transition Met Chem 1999, 24: 263-267.
22. Van Holde KE, Johnson WE and Ho PS. Principles of Physical Biochemistry. Upper Saddle River: Pearson Prentice Hall, 2006.
23. Chaires JB, Dattagupta N and Crothers DM. Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid. Biochemistry 1982, 21: 3933-3940.
24. Cohen G and Eisenberg H. Viscosity and sedimentation study of sonicated DNA-proflavine complexes. Biopolymers 1969, 8: 45-55.
25. Zhang M, Yang F, Jr, Yang F, Chen J, Zheng CY and Liang Y. Cytotoxic aggregates of a-lactalbumin induced by unsaturated fatty acid induce apoptosis in tumor cells. Chem Biol Interact 2009, 180: 131-142.
26. Satyanarayana S, Dabrowiak JC and Chaires JB. Neither D- nor Ltris( phenanthroline)ruthenium(II) binds to DNA by classical intercalation. Biochemistry 1992, 31: 9319-9324.
27. Satyanarayana S, Dabrowiak JC and Chaires JB. Tris( phenanthroline) ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding. Biochemistry 1993, 32: 2573-2584.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65: 55-63.
29. Tseng CH, Chen YL, Chung KY, Cheng CM, Wang CH and Tzeng CC. Synthesis and antiproliferative evaluation of 6-arylindeno[1,2-c]quinoline derivatives. Bioorg Med Chem 2009, 17: 7465-7476.
30. Katsarou ME, Efthimiadou EK, Psomas G, Karaliota A and Vourloumis D. Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities. J Med Chem 2008, 51: 470-478.
31. Darzynkiewicz Z, Robinson PJ and Crissman HA. Flow Cytometry. New York: Academic Press, 1994.
32. Riccardi C and Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006, 1: 1458-1461.
33. Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995, 184: 39-51.
34. Bhattacharjee RN, Park KS, Kumagai Y, Okada K, Yamamoto M, Uematsu S and Matsui K, et al. VP1686, a Vibrio type III secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kB Inhibition. J Biol Chem 2006, 281: 36897-36904.
35. Haq I, Ladbury JE, Chowdhry BZ, Jenkins TC and Chaires JB. Specific binding of hoechst 33258 to the d(CGCAAATTTGCG)2 duplex: calorimetric and spectroscopic studies. J Mol Biol 1997, 271: 244-257.
36. Barton JK. Metals and DNA: molecular left-handed complements. Science 1986, 233: 727-734.
37. Messori L, Orioli P, Vullo D, Alessio E and Lengo E. A spectroscopic study of the reaction of NAMI, a novel ruthenium(III)anti-neoplastic complex, with bovine serum albumin. Eur J Biochem 2000, 267: 1206-1213.
38. Rademaker-Lakhai JM, Van den Bongard D, Pluim D, Beijnen JH and Schellens JHM. A Phase I and pharmacological study with imidazoliumtrans- DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent. Clin Cancer Res 2004, 10: 3717-3727.
39. Tan J, Wang BC and Zhu LC. DNA binding, cytotoxicity, apoptotic inducing activity, and molecular modeling study of quercetin zinc(II) complex. Bioorg Med Chem 2009, 17: 614-620.
40. Wu JG, Ling X, Pan DL, Pasha A, Song L, Liang P and Altieri DC, et al. Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin. J Biol Chem 2005, 280: 9745-9751.
41. Mei HY and Barton JK. Tris(tetramethylphenanthroline)ruthenium(II): a chiral probe that cleaves A-DNA conformations. Proc Natl Acad Sci USA 1988, 85: 1339-1343.
42. Chen SH, Lin JK, Liang YC, Pan MH, Liu SH and Lin-Shiau SY. Involvement of activating transcription factors JNK, NF-kB, and AP-1 in apoptosis induced by pyrrolidine dithiocarbamate/Cu complex. Eur J Pharmacol 2008, 594: 9-17.